Evidence map›Paper›PMID 42910189›Full record

ArticleBrain communications2026

Viral heritability of neurocognitive performances in persons living with HIV and underlying viral residue variants.

Marius Zeeb, Mélanie Bieler-Aeschlimann, Paul Frischknecht, Kathrin Neumann, Lisa Jörimann, Jasmin Tschumi, Michael Huber, Katharina Kusejko, Enos Bernasconi, Helen Kovari and 14 more

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Marius ZeebDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.ORCID https://orcid.org/0000-0001-6822-1473
Mélanie Bieler-AeschlimannDivision of Infectious Diseases and Leenaards Memory Centre, Lausanne University Hospital, University of Lausanne, Lausanne 1011, Switzerland.
Paul FrischknechtDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.
Kathrin NeumannDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.ORCID https://orcid.org/0000-0001-5034-6999
Lisa JörimannDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.
Jasmin TschumiDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.ORCID https://orcid.org/0009-0007-4163-6338
Michael HuberInstitute of Medical Virology, University of Zurich, Zurich 8057, Switzerland.ORCID https://orcid.org/0000-0002-0384-0000
Katharina KusejkoDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.
Enos BernasconiDivision of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano 6500, Switzerland.ORCID https://orcid.org/0000-0002-9724-8373
Helen KovariCenter for Infectious Diseases, Klinik im Park, Zurich 8027, Switzerland.ORCID https://orcid.org/0000-0003-4896-4231
Karoline LeuzingerClinical Virology, University Hospital Basel, Basel 4031, Switzerland.
Julia NotterDivision of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen 9007, Switzerland.ORCID https://orcid.org/0000-0003-4821-9995
Matthieu PerreauDivision of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne 1011, Switzerland.ORCID https://orcid.org/0000-0003-2110-2244
Cornelia StaehelinDepartment of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.ORCID https://orcid.org/0000-0002-1733-7051
Alban RametteInstitute for Infectious Diseases and Multidisciplinary Center for Infectious Diseases, University of Bern, Bern 3012, Switzerland.
Marcel StöckleDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University Basel, Basel 4031, Switzerland.ORCID https://orcid.org/0000-0002-0088-5078
Sabine YerlyLaboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, University of Geneva, Geneva 1205, Switzerland.
Alexandra CalmyHIV/AIDS Unit, Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva 1205, Switzerland.
Karin J MetznerDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.
Huldrych F GünthardDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.
Matthias CavassiniDivision of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne 1011, Switzerland.ORCID https://orcid.org/0000-0003-0933-7833
Roger D KouyosDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich 8091, Switzerland.
NAMACO Study Group and the Swiss HIV Cohort Study
NAMACO Study Group and the Swiss HIV Cohort Study

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurocognitive impairments (NCI) affect up to 50% of persons living with HIV (PLWH), even under anti-retroviral therapy. Evidence suggests that HIV-1 genotypes at least in part contribute to NCI, but most studies considered composite scores and did not examine specific neurocognitive domains. We considered neurocognitive domains assessed in the Neurocognitive Assessment in the Metabolic and Ageing Cohort, a sub study of the Swiss HIV Cohort Study (SHCS), and determined associations with HIV-1 residues, detected by full-length genome sequencing, previously linked to self-reported neurocognitive complaints (SRNC) in the SHCS, using linear regression. Additionally, we determined the heritability with Brownian motion- and mixed models based on viral

Indexed as

cohort studiesHIVneurocognitive domainsneurocognitive impairmentviral genome

Identifiers

PMID42910189
PMCPMC13685630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.